Derm In-Review

03/06/2026

Friday Pop Quiz — LIVE! 🔬🩺

Can you pick the correct answer? Drop your best guess (A/B/C/D/E) in the comments — no peeking! The correct choice and full explanations for each option are posted on Next Steps in Derm. Head to our site to see if you got it right: https://ow.ly/3sv650Yq7tR

Good luck! 🍀💡

03/04/2026

Register Now: Core Crusher 2026!

You're invited to Core Crusher, Thursday, May 7, 2026.

Join the George Washington University School of Medicine & Health Sciences and Derm In-Review for the eighth annual Core Crusher!

Directed by Dr. Adam Friedman. Hosted by the George Washington University School of Medicine & Health Sciences and in Partnership with Derm In-Review

Register Now: https://ow.ly/JmK850YoG5p

Thursday, May 07, 2026 at 8:30 AM Eastern Daylight Time.

03/02/2026

Your first dermatology job after residency is more than just a paycheck — it sets the tone for your career, lifestyle, and long-term satisfaction. 💼✨

From private practice to academics, VA systems to locum tenens, every setting comes with unique tradeoffs. Before signing a contract, read these tips on evaluating job benefits from Derm In-Review Advisory Council Member Dr. Kelly O’Connor:
https://ow.ly/fj9u50Ynkh9

Remember: Your goal isn’t just a job — it’s finding the right environment that supports your professional growth, financial health, and work-life balance. Choose thoughtfully and negotiate confidently.

02/27/2026

It’s Friday… Pop Quiz time! 🧠✨ Can you guess the correct answer to this week’s derm board-style question?

Drop your best answer (A, B, C, D or E) in the comments ⬇️

Then head over to Next Steps in Derm to see if you got it right—full answer and explanations for every choice are now live: https://ow.ly/iE9i50YmZPc

02/24/2026

Sulfur–sulfacetamide is a classic workhorse in dermatology, offering antimicrobial, anti-inflammatory, and keratolytic benefits across multiple conditions. Commonly used for acne vulgaris, papulopustular rosacea, and seborrheic dermatitis, it remains especially useful in patients with rosacea–seborrheic dermatitis overlap—despite the rise of newer targeted therapies.

As with any topical, efficacy must be balanced with tolerability, as dryness and irritation are common. Our Therapeutic Cheat Sheet series continues with a practical review of sulfur–sulfacetamide, covering indications, safety considerations, and real-world prescribing pearls.

https://ow.ly/5npq50Yko7K

02/20/2026

FRIDAY POP QUIZ is LIVE! 🧠🔬
Think you know the right answer? Drop your pick (A, B, C, D, or E) in the comments ⬇️
Then head to Next Steps in Derm to see if you got it right—full answer and explanations for every choice are up now: https://ow.ly/q5yR50YiSpM

Tag a co-resident who’s studying too!

02/18/2026

We would like to thank our sponsors, Sanofi Regeneron for their support of the Derm In-Review Digital Study Guide!

The iconic exam prep guide is available in PDF format for on-the-go study, whenever, wherever. The digital study guide also includes a bonus chapter: CME In-Review! Download it today: https://ow.ly/18Kj50Yh73F

Sanofi is a R&D driven, AI-powered biopharma company committed to improving people’s lives and creating compelling growth. Their team is guided by one purpose: to chase the miracles of science to improve people’s lives. https://ow.ly/rRQl50Yh73H Regeneron, a leading biotechnology company, develops medicines for serious diseases. Founded by physician-scientists, their ability to translate science into medicine has led to numerous FDA-approved treatments and investigational candidates. https://ow.ly/ZxgW50Yh73E

02/17/2026

Pyoderma gangrenosum doesn’t always follow the bowel.

PG is a rare, painful neutrophilic dermatosis classically linked to systemic disease—especially IBD. But this "Great Cases from the JDD" is a reminder that PG can develop even after total colectomy and in the absence of active bowel disease.

📌 Case highlight:
A 55-year-old woman developed peristomal PG one year after colectomy for ulcerative colitis, with rapidly progressive, painful ulcers despite a clean ostomy. Treatment with intralesional triamcinolone followed by systemic adalimumab led to marked improvement within weeks.
Learn why this matters and clinical takeaways by reading the full case study: https://ow.ly/pa5q50Yhhm6

02/13/2026

FRIDAY POP QUIZ is live! Can you pick the correct answer? 🧠✨
Drop your best choice in the comments, then head over to Next Steps in Derm to see if you got it right—complete with the correct answer and explanations for the other options.

Ready, set, guess! https://ow.ly/WHLX50Yf9xB

02/10/2026

Thinking about life after residency can feel daunting. 😩

Derm In-Review Advisory Council Member Dr. Kristan Schiele says thinking about her future left her anxious and unsure. She wished there was a decision tree or Bolognia chart that could help her navigate the transition from resident to attending.

In this Next Steps in Derm article, Dr. Schiele shares lessons she’s learned while in the interview process, including:

✨ Start early with honest reflection about your values and vision
✨ Explore broadly before narrowing (even paths you don’t think you want)
✨ In-person visits matter more than you expect—culture, flow, and people are everything

Read Dr. Schiele’s experience with job searching and gain practical tips and encouragement: https://ow.ly/4aLn50YbNGU

02/10/2026

If each dermatology year were a song, what would the playlist be? 🎶

Comment with: PGY‑1: __ | PGY‑2: __ | PGY‑3: __ | PGY‑4: __ — and tag a co‑resident who needs this soundtrack. Best/funniest replies get a shoutout! ⬇️

(Need a spark? Example: PGY‑1: “Eye of the Tiger” 🐯)

02/06/2026

Friday Pop Quiz is live! Can you guess the correct answer? Drop your best choice (A/B/C/D/E) in the comments — then head to Next Steps in Derm to see the correct answer and full explanations: https://ow.ly/2ArM50Y9UUf

No peeking 😉 Good luck!